ClinicalTrials.gg
CompletedNCT07131865Updated Aug 20, 2025

Comparison of the Functional Status, Psychosocial Aspects and Discharge Locations of Geriatric Patients Before and After Inpatient Geriatric Rehabilitation

An observational study in Weak; Senile, Old Age; Debility and Movement Disorders, sponsored by University of Bern. Completed at 1 site in Switzerland. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-08-20.

Primary conditionAsthenia(the registry's first term)UnverifiedIs this wrong?Asthenia is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by University of Bern · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
753
Ages
65 Years and older
Sex
All
01

Study summary

Due to demographic change in Switzerland, the proportion of older people in the population is expected to increase. It is therefore important that people in old age remain in the best of health and maintain their independence for a long time.

To this end, the investigators would like to demonstrate the effectiveness of inpatient geriatric rehabilitation at the Valens clinics. This will be done by comparing independence, quality of life, physical and mental health, mobility and hand strength on admission and discharge.

02

Conditions studied

  • Weak; Senile
  • Old Age; Debility
  • Movement Disorders
  • Quality of Life
  • Sarcopenia

Browse trials for

Keywords

  • Rehabilitation
  • Geriatrics
  • Effectiveness
  • Frailty
03

In context

Asthenia Unverified

77 studies on the registry are indexed under Asthenia; 16 are open to participants now.

This study's enrollment of 753 is above the median of 113 across 13 observational studies indexed under Asthenia.

Browse Asthenia studies →

Lead sponsor

University of Bern is the lead sponsor of 209 studies on the registry; 47 are open to participants now.

Compared within Asthenia, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Age greater than 65 years

Presence of multimorbidity

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients who were treated as inpatients at the Kliniken Valens Geriatric Rehabilitation according to ICF criteria between 2020 and 2023 will be included.
  • Signed the general consent for the further use of their health-related data for research, version 1.2, dated November 18, 2019.

Exclusion criteria

Exclusion Criteria:

  • No written consent was provided.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
753 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Classification of diagnosis into internal medicine, neurological, or orthopedic/surgical categories

    Number of participants with diagnoses are divided into 3 groups: internal medicine, neurology and orthopedic/surgical. The diagnoses are determined and documented at hospital admission based on prior clinical assessments, laboratory results, and imaging studies. They are classified into one of three categories: Internal medicine (e.g., cardiovascular, respiratory diseases), Neurological (e.g., stroke, neuropathies) or Orthopedic/surgical (e.g., fractures, joint disorders). This classification reflects the patient's primary diagnosis at the time of study enrollment.

    Time frame: At baseline (upon hospital admission and study enrollment)

  2. Cumulative Health Rating Scale (CIRS)

    The Cumulative Illness Rating Scale is a tool used to measure the overall burden of chronic illnesses across multiple organ systems. Each system is rated from 0 (no problem) to 4 (severe problem), and the scores are added up to reflect a patient's total morbidity. It is commonly used in geriatrics to assess multimorbidity and help predict health outcomes.

    Time frame: At baseline (upon hospital admission and study enrollment)

  3. Functional Independence Measure (FIM)

    The FIM assesses how independently a person can perform daily activities. It uses an 18-item scale covering motor and cognitive tasks, each rated from 1 (total assistance needed) to 7 (complete independence). The total score reflects the level of disability and the amount of assistance required for daily living. Higher scores mean greater independence.

    Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days

  4. Health-related quality of life (EQ5D-5VAS)

    The EQ-5D-5VAS is a brief, standardized questionnaire for measuring health-related quality of life. It consists of two parts Descriptive system: Assesses five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-each with five levels of severity, allowing patients to describe their health state precisely and Visual Analogue Scale (VAS): Patients rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health), providing a quantitative self-assessment

    Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days

  5. Patient Reported Outcomes Measurement Information System - (PROMIS-10)

    It is a short, 10-item questionnaire that measures subjective physical and mental health from the patient's perspective. It covers areas like physical function, pain, fatigue, emotional distress and social health. It helps researchers understand how the patients are feeling in terms of both body and mind. Higher scores indicate better health.

    Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days

  6. Timed Up and Go Test (TUG)

    The Timed Up and Go (TUG) test is a simple test for assessing mobility and balance. The person stands up from a chair, walks three meters, turns around, walks back, and sits down again. The time required to complete the task is measured.

    Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days

  7. Grip strength measured by the Jamar Hand Dynamometer

    The Jamar Hand Dynamometer is a standardized instrument used to measure grip strength, which reflects the maximum force exerted by the hand muscles during a squeeze. The grip strength is an important functional outcome and indicator of overall muscle strength and physical health. It is a reliable, non-invasive, and easy-to-administer test that provides valuable information about the participant's muscular strength and functional status. Participants will be asked to squeeze the dynamometer handle with maximum effort for a few seconds. The device will record the force applied, reported in kilograms.

    Time frame: At baseline (upon hospital admission and study enrollment) and at discharge from the clinic after a stay of approx. 21 days

Secondary outcomes

  1. Age of participants

    Participant age will be recorded in years at the time of study enrollment. Age is an important demographic variable used to characterize the study population and to analyze outcomes by age groups if applicable.

    Time frame: At baseline (upon hospital admission and study enrollment)

  2. Gender of participants

    Participant gender will be recorded as male, female, or other at the time of study enrollment. Gender is a key demographic variable to describe the study population and analyze potential differences in outcomes.

    Time frame: At baseline (upon hospital admission and study enrollment)

  3. Marital status of participants

    Marital status will be recorded at the time of study enrollment and categorized as single, married, divorced, widowed, or other. This demographic information helps to characterize the study population and may be used to analyze its influence on health outcomes.

    Time frame: At baseline (upon hospital admission and study enrollment)

  4. Place of residence of participants

    Participants' place of residence will be recorded at the time of study enrollment. This information may include urban or rural status, region, or postal code. It helps to describe the study population and assess potential geographic influences on health outcomes.

    Time frame: At baseline (upon hospital admission and study enrollment)

  5. Length of hospital stay

    The length of hospital stay will be recorded in days, calculated from the date of admission to the date of discharge. This measure reflects the duration of inpatient treatment and may be used to evaluate resource utilization and recovery time.

    Time frame: From the beginning of the study (at hospitalization and admission to the study) until discharge from the clinic after a stay of approx. 21 days

07

Study locations

1 site
  • Kliniken Valens, Rehazentrum Walenstadtberg
    Walenstadtberg, St.Gallen 8881, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07131865
Lead sponsor
University of Bern
Responsible party
Sponsor
First posted
Aug 20, 2025
Start date
Jan 1, 2020
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Aug 20, 2025

Study contacts

Prof. Dr. Stefan Bachmann, Prof. Dr. med.
study chair · University of Bern, Kliniken Valens

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion